Problems of Social Hygiene, Public Health and History of MedicineProblems of Social Hygiene, Public Health and History of Medicine0869-866X2412-2106Joint-Stock Company Chicot58910.32687/0869-866X-2021-29-s1-603-606Научная статьяAnalysis of the development of acute coronary syndrome during the COVID-19 pandemicOrlovaN. V.vrach315@yandex.ruGololobovaT. V.-SuranovaT. G.-SpiryakinaYa. G.-ChuvarayanG. A.-LomaichikovV. V.-PetrenkoA. P.-Pirogov Russian National Research Medical UniversityScientific Research Disinfectology Institute of the Federal Service for Surveillance on Consumer Rights Protection and Human WelfareRussian Medical Academy of Continuous Professional EducationFederal Research and Clinical Center of the Federal Medical-Biological Agency1506202129S160360605082021Copyright © 2021,2021The study compares two groups of patients with acute coronary syndrome, depending on the presence of COVID-19 in the anamnesis. The comparison groups analyzed the risk factors for cardiovascular diseases, including smoking, heredity, gender differences, age, diabetes, and obesity. The results of biochemical blood tests were analyzed. It was found that patients with acute coronary syndrome who underwent COVID-19 were less likely to have risk factors for cardiovascular diseases. Patients with acute coronary syndrome who underwent COVID-19 were found to have lower blood glucose, cholesterol, very-low-density lipoprotein, and triglycerides. As a result of the study, it was revealed that COVID-19 is an independent risk factor for the development of acute coronary syndrome.COVID-19COVID-19acute coronary syndromerisk factors for cardiovascular diseasesострый коронарный синдромфакторы риска сердечно-сосудистых заболеваний1.Driggin E., Madhavan M. V., Bikdeli B. et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic // J. Am. Coll. Cardiol. 2020. Vol. 75, N 18. P. 2352-2371. DOI: 10.1016/j.jacc.2020.03.031.2.Yaghi S., Ishida K., Torres J. et al. SARS-CoV-2 and stroke in a New York healthcare system // Stroke. 2020. Vol. 51, N 7. P. 2002-2011. DOI: 10.1161/STROKEAHA.120.030335.3.Musher D. M., Abers M. S., Corrales-Medina V. F. Acute infection and myocardial infarction // N. Engl. J. Med. 2019. Vol. 380, N 2. P. 171-176. DOI: 10.1056/NEJMra1808137.4.Sandoval Y., Jaffe A. S. Type 2 myocardial infarction: JACC review topic of the week // J. Am. Coll. Cardiol. 2019. Vol. 73, N 14. P. 1846-1860. DOI: 10.1016/j.jacc.2019.02.018.5.Mauriello A., Sangiorgi G., Fratoni S. et al. Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction // J. Am. Coll. Cardiol. 2005. Vol. 45, N 10. P. 1585-1593. DOI: 10.1016/j.jacc.2005.01.054.6.Kwong J. C., Schwartz K. L., Campitelli M. A. et al. Acute myocardial infarction after laboratory-confirmed influenza infection // N. Engl. J. Med. 2018. Vol. 378, N 4. P. 345-353. DOI: 10.1056/NEJMoa1702090.7.Barnes M., Heywood A. E., Mahimbo A. et al. Acute myocardial infarction and influenza: a meta-analysis of case-control studies // Heart. 2015. Vol. 101, N 21. P. 738-747. DOI: 10.1136/heartjnl-2015-307691.8.Auer J., Berent R., Weber T., Eber B. Influenza virus infection, infectious burden, and atherosclerosis // Stroke. 2002. Vol. 33, N 6. P. 1454-1455. DOI: 10.1161/01.str.0000018667.77849.95.9.Madjid M., Aboshady I., Awan I. et al. Influenza and cardiovascular disease: is there a causal relationship? // Tex. Heart Inst. J. 2004. Vol. 31, N 1. P. 4-13.10.Puntmann V. O., Carerj M. L., Wieters I. et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) // JAMA Cardiol. 2020. Vol. 5, N 11. P. 1265-1273. DOI: 10.1001/jamacardio.2020.3557.11.Belani P., Schefflein J., Kihira S. et al. COVID-19 is an independent risk factor for acute ischemic stroke //Am. J. Neuroradiol. 2020. Vol. 41, N 8. P. 1361-1364. DOI: 10.3174/ajnr.A6650.